Citadel Advisors
SXTPW icon

Citadel Advisors’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Citadel Advisors’s Portfolio SXTPW Stock Details SXTPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$621 Sell
12,400
-3,174
-20% -$204 ﹤0.01% 12843
2025
Q4 		$978 Sell
15,574
-5,221
-25% -$255 ﹤0.01% 12489
2025
Q3 		$769 Buy
20,795
+3,127
+18% +$215 ﹤0.01% 12604
2025
Q2 		$783 Sell
17,668
-24,754
-58% -$1.28K ﹤0.01% 12274
2025
Q1 		$976 Sell
42,422
-5,253
-11% -$145 ﹤0.01% 14190
2024
Q4 		$1.71K Buy
47,675
+1,402
+3% +$41 ﹤0.01% 14153
2024
Q3 		$2.79K Buy
46,273
+7,231
+19% +$417 ﹤0.01% 13718
2024
Q2 		$2.74K Buy
39,042
+11,527
+42% +$1.07K ﹤0.01% 13656
2024
Q1 		$4.13K Buy
+27,515
New +$2.2K ﹤0.01% 13836

Other funds holding SXTPW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's SXTPW Position: Q1 2026 in Review

Citadel Advisors reduced its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 20% in Q1 2026, selling an estimated $204 and leaving 12,400 shares worth $621. The position accounts for ﹤0.01% of the portfolio, ranked #12843.

Citadel Advisors first reported a position in SXTPW in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.13K in Q1 2024. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

  • Citadel Advisors held 12,400 shares of 60 Degrees Pharmaceuticals Warrant worth $621 as of Q1 2026.
  • Citadel Advisors sold 3,174 60 Degrees Pharmaceuticals Warrant shares in Q1 2026, an estimated $204.
  • 60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12843 holding.
  • Citadel Advisors first reported a position in 60 Degrees Pharmaceuticals Warrant in Q1 2024 and has held it in 9 quarters since.
  • Citadel Advisors's 60 Degrees Pharmaceuticals Warrant position peaked at $4.13K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.